Gemma-Claire Ali

Photo of Gemma-Claire Ali
Analyst
Cambridge Office

Education

M.Sc. in global mental health, London School of Hygiene & Tropical Medicine / King's College London; M.A. in geography, University of Cambridge

Overview

Gemma-Claire Ali (she/her) is an analyst at RAND Europe with seven years of professional experience in public health research, the last three of which have focused on the interface between health and emerging technologies. She specialises in the full breadth of literature review types and a wide range of qualitative research methods, including surveys, interviews, focus groups and case studies.

At RAND Europe, she has worked on several projects involving evidence synthesis to inform policymaking and strategy development in the fields of health and innovation. In particular, she has recently completed two large scoping reviews of digital innovations implemented in response to the COVID-19 pandemic, commissioned by the European Centre for Disease Prevention and Control (ECDC). This followed a broader scoping review of the use of emerging technologies for infectious disease surveillance, prevention and control, also commissioned by the ECDC.

Other relevant projects include understanding the impact of the COVID-19 pandemic on work-related musculoskeletal disorders, commissioned by the Health and Safety Executive, and a historical foresight study of antimicrobial resistance (AMR) commissioned by the AHRC. This last project drew on literature reviews, interviews, policy workshops and foresight methods to understand how AMR, tobacco control and climate change have developed as policy issues over time, and to inform future AMR policy.

She holds an M.A. in geography from the University of Cambridge, an M.Sc. from the London School of Hygiene & Tropical Medicine and King’s College London, and is completing her Ph.D. part-time at the University of Cambridge.

Recent Projects

  • The impact of COVID-19 on work-related musculoskeletal disorders
  • Assessment of digital innovations implemented in response to COVID-19
  • Impact of antimicrobial resistance on modern medicine - a scoping review
  • Assessment of digital technologies for infectious disease surveillance, prevention and control
  • Historical foresight and comparative approaches to inform antimicrobial resistance policy

Languages

English (native); French (independent)

Commentary

  • Patient communicates with her doctor via a laptop for advice, photo by Henfaes/Getty Images

    What Influences Quality Improvement Processes in Health Care?

    Periods of rapid change offer both opportunities and challenges for health care quality improvement. Understanding the building blocks that need to be in place to support improvement processes may help those seeking to embed improvement capabilities and capacity into their organisations, both as we emerge from the COVID-19 pandemic and beyond.

    Nov 10, 2020 The RAND Blog

Publications